Blackford and Thirona Partner to Enhance Lung Image Analysis
Leyla Suleymanova2024-08-20T10:02:01+00:00Blackford and Thirona announce a commercial partnership to bring the LungQ™ solution to healthcare professionals via the Blackford Platform.
Blackford and Thirona announce a commercial partnership to bring the LungQ™ solution to healthcare professionals via the Blackford Platform.
Voiant and Thirona have entered a global commercial partnership to provide full scope integral services for clinical trials (with AI-powered lung image analysis), building further on several years of a fruitful cooperation.
Thirona has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest update of its AI-based clinical software LungQ™ (v3.0.0)
MedTech companies Aidence, Incepto, and Thirona jointly introduce a comprehensive AI-powered software package for lung cancer screening and the analysis of emphysema
Thirona is thrilled to have secured €7,5 Million ($8 Million) of financing from HERAN Partners, Borski Fund and the EIC.
Following the second 2023 EIC Accelerator cut-off in March, Thirona is awarded to receive European Innovation Council (EIC) funding.
Thirona’s AI-Based LungQ™AVX Reveals New Potential for Treatment of Vascular Diseases.
2 abstracts of major importance for advancing the treatment of pulmonary vascular diseases, and pulmonary hypertension in particular, were presented today at ATS 2023 International Conference in Washington by Julien Guiot from CHU de Liège.
Bringing AI into clinical care through integration partnerships with Philips & Incepto.
On November 24th the matchmaking in healthcare event took place, organized by the Netherlands AI coalition
American Thoracic Society 2022 was a great opportunity to meet the respiratory expert community